Myocardial perfusion imaging using single-photon emission computed tomography
- PMID: 8032191
Myocardial perfusion imaging using single-photon emission computed tomography
Abstract
Myocardial perfusion single-photon emission computed tomography (SPECT) provides three-dimensional physiological information to assess myocardial blood flow at stress and rest and myocardial viability. The availability of perfusion agents with different uptake mechanisms, thallium 201, technetium 99m-sestamibi, and 99mTc-teboroxime, has created considerable flexibility in how these agents are imaged and interpreted. The higher photon flux and fixed distribution of 99mTc sestamibi allows for multiple-gated acquisition, which yields the potential for the assessment of myocardial thickening. Pharmacological agents, such as dipyridamole, adenosine, and dobutamine, may be used with myocardial perfusion SPECT as an alternate stress procedure in patients who cannot exercise adequately. SPECT reconstruction is limited by the current lack of clinically implemented algorithms to compensate for photon scatter and attenuation or for finite spatial resolution. Data-based quantification procedures that compare a patient's results to a database of normal patients assist the diagnosticians in circumventing these limitations.
Similar articles
-
The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.Circulation. 1991 Sep;84(3 Suppl):I7-21. Circulation. 1991. PMID: 1832100 Review.
-
Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease.Am J Cardiol. 1990 Oct 16;66(13):55E-62E. doi: 10.1016/0002-9149(90)90613-6. Am J Cardiol. 1990. PMID: 2145748 Review.
-
Technetium-labeled myocardial perfusion agents.Cardiol Clin. 1994 May;12(2):187-98. Cardiol Clin. 1994. PMID: 8033172 Review.
-
Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability.Am J Cardiol. 1990 Oct 16;66(13):72E-79E. doi: 10.1016/0002-9149(90)90616-9. Am J Cardiol. 1990. PMID: 2145750
-
Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.J Nucl Med. 1995 Nov;36(11):2009-15. J Nucl Med. 1995. PMID: 7472590 Clinical Trial.
Cited by
-
Magnetic resonance perfusion imaging in patients with coronary artery disease: a qualitative approach.Int J Cardiovasc Imaging. 2002 Oct;18(5):373-83; discussion 385-6. doi: 10.1023/a:1016057821005. Int J Cardiovasc Imaging. 2002. PMID: 12194678
-
Understanding Fourier space and filter selection.J Nucl Cardiol. 1997 May-Jun;4(3):234-43. doi: 10.1016/s1071-3581(97)90084-2. J Nucl Cardiol. 1997. PMID: 9199261 Review. No abstract available.
-
Functional cardiac magnetic resonance imaging (MRI) in the assessment of myocardial viability and perfusion: an evidence-based analysis.Ont Health Technol Assess Ser. 2003;3(6):1-82. Epub 2003 Nov 1. Ont Health Technol Assess Ser. 2003. PMID: 23074446 Free PMC article.
-
Fusion imaging: combined visualization of 3D reconstructed coronary artery tree and 3D myocardial scintigraphic image in coronary artery disease.Int J Card Imaging. 1999 Oct;15(5):357-68; discussion 369-70. doi: 10.1023/a:1006232407637. Int J Card Imaging. 1999. PMID: 10595402
-
Early assessment of myocardial contractility by contrast-enhanced magnetic resonance (ceMRI) imaging after revascularization in acute myocardial infarction (AMI).Korean J Intern Med. 2004 Dec;19(4):213-9. doi: 10.3904/kjim.2004.19.4.213. Korean J Intern Med. 2004. PMID: 15683109 Free PMC article.